STRUCTURE THERAPEUTICS INC

About

Structure Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing novel small molecule therapeutics for the treatment of metabolic and fibrotic diseases. The company leverages its structure-based drug discovery platform to target G protein-coupled receptors (GPCRs), aiming to create oral treatments as alternatives to injectable peptide-based therapies. Its primary pipeline candidate targets conditions such as type 2 diabetes and obesity.